ShareValue scores for 600812.SHG: Valuation 62, Quality 43, Growth 38, Health 33.

600812.SHG
SSE

North China Pharmaceutical Co Ltd

CN¥4.96(+4.20%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 17%
Valuation
62
Fair Value
Price vs Value
Quality
43
Moderate
Business Strength
Growth
38
Weak
Revenue & Earnings
Health
33
Stressed
Financial Stability
Momentum
38
Bearish
Price Trend

Company Details

About

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical, biological, agricultural, and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026